Hyperammonemic Encephalopathy Associated with 5-Flurouracil Infusion in Head and Neck Cancer: Case Report and Review of the Literature
Hyperammonemic encephalopathy is an uncommon, potentially lethal adverse effect of 5-fluorouracil (5-FU). Being one of the most common and versatile chemotherapy agents, it is important to understand this important side effect of 5FU. There is paucity of data in this subject. Here, we report a case...
Main Authors: | Saikat Das, Aftab Ahmad, Pallav Prasun, Vipin Kharade, Manish Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021-09-01
|
Series: | Journal of Neurosciences in Rural Practice |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1736154 |
Similar Items
-
Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus
by: Giulia Cagnotti, et al.
Published: (2018-06-01) -
Neuro-Oncology: An Emerging Neurologic Subspecialty in Thailand
by: Sith Sathornsumetee
Published: (2020-04-01) -
Valproate Associated Hyperammonemic Encephalopathy
by: Wadzinski, Jim, et al.
Published: (2007) -
Valproate-Induced Hyperammonemic Encephalopathy
by: J Gordon Millichap
Published: (2006-07-01) -
Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01)